Advanced (unresectable and/or metastatic) leiomyosarcoma or liposarcoma

Treatment Phase: Continuing treatment

Clinical criteria:

• Patient must have previously received PBS-subsidised treatment with this drug for this condition,

AND

• Patient must not have developed disease progression while receiving treatment with this drug for this condition,

AND

• The treatment must be the sole PBS-subsidised systemic anti-cancer therapy for this condition.

This drug is not PBS-subsidised if it is administered to an in-patient in a public hospital setting.